WebDec 7, 2024 · In fiscal year 2024, the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd generated a revenue of close to 3.6 trillion Japanese yen, the … WebDec 7, 2024 · The statistic shows the revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2016, broken down by segment. ... Basic Statistic Annual revenue of Sobi 2009-2024; Basic Statistic ...
Takeda Pharmaceutical Company - AnnualReports.com
WebJan 11, 2024 · Takeda’s pipeline portfolio has the potential to contribute significantly to revenue growth and the company has a goal to reach JPY5 trillion ($47 billion) revenue by FY2030 1, representing... WebJan 23, 2024 · Takeda had 34% of its 2024 revenues from Japan, 34% from the US, 17% from Europe and Canada, and 16% from emerging markets. A combined Shire/Takeda on a pro forma revenue basis would have 48% of its revenues from the US, 33% from international markets, and 19% from Japan. dr amber ristow
Takeda Pharmaceutical: revenue 2024 Statista
WebMay 12, 2024 · Takeda Pharmaceutical has reported a 2.8% year-on-year (YOY) decrease in its reported revenue to JPY3,197.8bn ($29.4bn) during the fiscal year 2024 (FY2024) ended 31 March 2024. This decline is attributed mainly to foreign exchange and divestitures. WebTakeda Pharmaceutical Quarterly and Annual Revenue Trailing 12-Months Trend (TTM) Annual Revenue $30.4B Takeda Pharmaceutical's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 33.5B. Over the last four quarters, Takeda Pharmaceutical's revenue has decreased by 31.5%. WebOct 8, 2024 · Takeda’s fiscal year runs from April 1 through March 31. Takeda’s fiscal first quarter runs from April 1 through June 30) 2024 Revenue $30,568 Net income $411 Diluted EPS $0.26 R&D expense $4,573 1Q 2024 Revenue $7,447 Net income $766 Diluted EPS $0.49 R&D expense $992 BEST-SELLING Rx PRODUCTS dr amber plante chiropractor usa new address